drugset / Trial / NCT04729582
Autologous Muscle Stem Cell Therapy for Treatment of Congenital Urinary Incontinence in Epispadias Patients
Phase 1/2
Not yet recruiting
21 enrolled
Simone Spuler, MD
German Federal Ministry of Education and Research · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this trial is to evaluate the safety and efficacy of an autologous muscle stem cell therapy in the treatment of congenital urinary incontinence in isolated epispadias.
Timeline
- Start
- 2024-06
- Primary completion
- 2026-08
- Completion
- 2026-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Satori-01 | Cell therapy | — | Other |